As of 06 Nov 2026 15:10 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2025/072 (23 Dec 2025): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Only the reuseable pen devicenamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 23 Dec 2025 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Only the reuseable pen device — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Genotropin
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 23 Dec 2025. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 23 Dec 2025 | Medicine Supply Notification: Genotropin® (somatropin) 5.3 mg and 12 mg powder and solvent for solution for injection | Supply notification | Tier 2 | MSN/2025/072 |
Also recorded under
Bracketed names seen in this medicine's notice titles: somatropin. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2025)58 Pen device for Genotropin® (somatropin) 5.3 mg and 12 mg powder and solvent · issued 30 Dec 2025 · valid until early 2027, as stated · matched by name PDF ↗
- MSAN(2024)31 Somatropin (NutropinAq®) 10mg/2ml solution for injection cartridges · issued 30 May 2024 · valid until Products have been discontinued, as stated · matched by the recorded name “somatropin” PDF ↗
- MSAN(2023)28 Somatropin (Genotropin® MiniQuick) 1.4mg powder and solvent for solution for · issued 29 Sep 2023 · valid until w/c 1st January 2024, as stated · matched by name PDF ↗
- MSAN(2023)11 Norditropin® Flexpro® and NordiFlex® (somatropin) solution for injection pre- · issued 09 Jun 2023 · valid until September 2023, as stated · matched by the recorded name “somatropin” PDF ↗